the effective concentration of sevoflurane combined with cisatracurium in neonatal anesthesia induction and the respective optimal dosage combined with remifentanil in maintance of neobatal anesthesia

An Observational Study of Sevoflurane On Anesthesia Induction and Maintanance For Neonate

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OIC-16008020

Enrollment

Unknown

Registered

2016-02-29

Start date

2016-02-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

An Observational Study of Sevoflurane On Anesthesia Induction and Maintanance For Neonate

Interventions

neonate:modify medication dosage

Eligibility

Sex/Gender

All

Age

1 Years to 1 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-III, below 28 days after birth; 2. neonate without airway diease; 3. neonate without congenital heart diease and risk for aspiration; 4. neonate undergoing tracheal intubation under general anesthesia for non laparoscopic abdominal surgery.

Exclusion criteria

Exclusion criteria: 1. ASA Classification above III; 2. Neonate with airway diease, congenital heart diease and risk for aspiration; 3. Allergy to study related medication.

Design outcomes

Primary

Measure	Time frame
Blood pressure;heart rate;	—

Countries

China

Contacts

Public ContactFeng Qi

zb000307@hotmail.com+86 18560083756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026